Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.3%

4 terminated/withdrawn out of 55 trials

Success Rate

89.7%

+3.2% vs industry average

Late-Stage Pipeline

5 trials in Phase 3/4

Results Transparency

11%

4 of 35 completed trials have results

Key Signals

3 recruiting4 with results

Enrollment Performance

Analytics

N/A

46(83.6%)

Phase 2

3(5.5%)

Phase 3

3(5.5%)

Phase 4

2(3.6%)

Phase 1

1(1.8%)

55Total

N/A(46)

Phase 2(3)

Phase 3(3)

Phase 4(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials

NCT06462651Not ApplicableCompleted

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic

Role: lead

NCT07347743Not ApplicableRecruiting

Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.

Role: collaborator

NCT07190859Not ApplicableRecruiting

Evaluating the Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic

Role: lead

NCT05512234Not ApplicableRecruiting

Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic

Role: lead

NCT03366077Not ApplicableCompleted

Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection in Adult Women

Role: lead

NCT05548361Not ApplicableCompleted

The Use of Chlorhexidine and a Probiotic Lozenge in the Nonsurgical Therapy of Periodontitis

Role: collaborator

NCT01603368Phase 2Completed

Prophylactic Probiotics to Extremely Low Birth Weight Prematures

Role: collaborator

NCT06026228Not ApplicableNot Yet Recruiting

Effects of Probiotic Oral Intake on Plasma Chlordecone (Kepone) Concentrations in Individuals Environmentally Exposed to Pesticide in Martinique.

Role: collaborator

NCT03660280Not ApplicableCompleted

Probiotics to Treat "Inflammatory Depression"

Role: collaborator

NCT04037826Not ApplicableCompleted

L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults

Role: collaborator

NCT04169789Not ApplicableCompleted

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri

Role: collaborator

NCT04767711Not ApplicableCompleted

Prevention of Glucocorticoid Induced Impairment of Bone Metabolism

Role: collaborator

NCT04847960Not ApplicableUnknown

The Effect of Probiotic Lactobacillus Reuteri Prodentis Consumption on Gingival Crevicular Fluid Inflammatory Response and Metagenomic Profiles of Oral Microbiome in Orthodontic Patients.

Role: collaborator

NCT03030664Not ApplicableCompleted

Effect of L. Reuteri on Bowel Movements in Children (BIOWELL Study)

Role: collaborator

NCT04606186Not ApplicableUnknown

Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatment in Adult Patients

Role: collaborator

NCT04598633Not ApplicableUnknown

Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatment

Role: collaborator

NCT03106285Not ApplicableWithdrawn

Effectiveness of Probiotic Supplementation on Crying Time in Infantile Colic

Role: lead

NCT05044949Not ApplicableCompleted

Study Evaluating the Safety and Tolerability of a Probioitc

Role: lead

NCT05165589Not ApplicableUnknown

Validation of Active-Insights Device to Measure Crying Time

Role: lead

NCT04734886Not ApplicableCompleted

The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19

Role: collaborator